ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Surescripts Names Lynne Nowak as First Chief Data and Analytics Officer

Surescripts®, the nation’s leading health information network, has named Lynne Nowak, M.D., as its first Chief Data and Analytics Officer. In this role, Nowak’s team will work across the Surescripts Network Alliance to optimize the value of the data delivered across the network.

“After more than 20 years operating a nationwide health information network, we remain committed to being the standard bearer when it comes to connecting clinicians with the patient intelligence they need, whenever and wherever they need it,” said Frank Harvey, Chief Executive Officer for Surescripts. “Lynne’s experience and vision aligns with Surescripts’ purpose, and we welcome her leadership as we continue advancing interoperability and technology that helps clinicians to provide better, safer and less costly care in America.”

In 2022, Surescripts safely and securely exchanged more than 21.7 billion health information transactions, serving as the industry’s best example of healthcare interoperability. Surescripts connects more than 2 million healthcare professionals and organizations with trusted healthcare intelligence for over 99% of American patients.

“Healthcare will never stop evolving and I’m excited to join Surescripts, bringing my experience as a clinician but also a data and analytics expert, to continue leading innovations in health information technology and advancing interoperability,” said Lynne Nowak, Chief Data and Analytics Officer for Surescripts. “I share Surescripts’ vision of a healthcare system that is truly patient-centered and look forward to advancing Surescripts’ purpose by optimizing how information is shared and creating efficiencies that help clinicians deliver meaningful, accessible and more affordable care to their patients.”

Background:

Lynne Nowak brings nearly 30 years of healthcare experience, including over 10 years leading data science, data product and business analytics teams. She spent 15 years practicing as a board certified internal medical physician which included founding an inpatient hospitalist practice and serving as medical director of a hospice.

Most recently, she served as Chief Medical Officer at Lark Health where she led Business Insights, Analytics Engineering, Clinical Studies and Research, and Clinical Strategy. She also worked very closely with Lark’s sales and strategy teams responsible for business development and fostering new strategic partnerships and business opportunities.

Prior to Lark Health, Lynne served as Vice President/General Manager of Clinical Data and Provider Solutions at Cigna/Evernorth/Express Scripts. In her time at Express Scripts, Lynne worked very closely with the Surescripts team to implement solutions such as ePA, Real Time Prescriptions Benefits, and Record Location and Exchange. Lynne was also responsible for compliance with and implementation of all health information interoperability and price transparency regulations for the Cigna enterprise.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us at twitter.com/surescripts.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.16
-0.51 (-0.22%)
AAPL  277.55
+0.58 (0.21%)
AMD  214.24
+8.11 (3.93%)
BAC  52.99
+0.51 (0.97%)
GOOG  320.28
-3.36 (-1.04%)
META  633.61
-2.61 (-0.41%)
MSFT  485.50
+8.51 (1.78%)
NVDA  180.26
+2.44 (1.37%)
ORCL  204.96
+7.93 (4.02%)
TSLA  426.58
+7.18 (1.71%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.